Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study
Sarah C. Rutherford, Jeremy S Abramson, Nancy L. Bartlett, Stefan K. Barta, Nadia Khan, Robin Joyce, Kami J. Maddocks, Trisha Ali-Shaw, Silvia Senese, Ying Yuan, Jason R. Westin, John P. Leonard
Topics & Concepts
MedicineVincristineVenetoclaxEtoposideEpoch (astronomy)RituximabInternal medicineLymphomaPrednisoneCyclophosphamideInternational Prognostic IndexAggressive lymphomaGastroenterologyOncologySurgeryChemotherapyLeukemiaChronic lymphocytic leukemiaPhysicsStarsAstronomyAcute Lymphoblastic Leukemia researchCell death mechanisms and regulationChronic Lymphocytic Leukemia Research